The Methodist Hospital System

Health

Toasting your health: Take care with alcohol consumption

(Medical Xpress)—The holidays are a time to consume—food, gifts, and spirits. Here are a few alcohol-related story ideas from The Methodist Hospital. Because alcohol's effects on human physiology are complex, advice about ...

Cardiology

A simpler way to predict heart failure

(Medical Xpress)—The most widely used models for predicting heart failure rely on a complex combination of lifestyle, demographic, and cardiovascular risk factor information.

Alzheimer's disease & dementia

Outlining the risk factors to help prevent dementia

(Medical Xpress)—Research shows that managing and treating vascular disease risk factors are not only beneficial to preventing heart disease and stroke, but also common forms of dementia.

Oncology & Cancer

3-D model for lung cancer mimics the real thing

(Medical Xpress)—A new technique that allows scientists to grow lung cancer cells in three dimensions could accelerate discoveries for a type of cancer that has benefited little from scientific research over the last several ...

Surgery

Brain tumor removal through a hole smaller than a dime

More than two decades ago, Ryan Vincent had open brain surgery to remove a malignant brain tumor, resulting in a lengthy hospital stay and weeks of recovery at home. Recently, neurosurgeons at Houston Methodist Hospital removed ...

Health

Eating clean by going green this spring

The energetic and radiant hue of emerald green has been declared the spring color of 2013. While green shirts, pants and jackets will be seen everywhere this season, so should green food on your plate.

Health

5 tips to stay safe during the marathon

(Medical Xpress)—On the morning January 13th, 2013, 25,000 people will meet at the George R Brown convention center for the biggest one day sporting event in Houston.  Many of you will be running 26.2 miles for the first ...

Medications

FDA approves drug to treat diabetic macular edema

The U.S. Food and Drug Administration today announced its approval of Lucentis (ranibizumab injection) for the treatment of diabetic macular edema, or DME, an eye condition in people with diabetes that causes blurred vision, ...

page 2 from 2